Cipla Ltd is set to invest ZAR 900 million in its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Ltd. The ...

Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

Cipla Ltd is one of the leading pharmaceutical companies in India ... Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1500 products across wide range of th... We ...

The company reported a 48% year-on-year (y-o-y) jump in its consolidated net profit to ₹1,571 crore in October-December, ...

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical ...

Asit C Mehta recommended accumulate rating on Cipla with a target price of Rs 1808 in its research report dated January 17 ...

Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has ... Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and ...

Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 Cipla Q3 Net Profit Soars 49% to Rs 1,571 Crore Cipla's net profit surged 49% to Rs 1,571 crore in Q3 FY25, driven by strong revenue ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

Pharma major Cipla Ltd on Monday said it will invest about ZAR 900 million (nearly Rs 415 crore) in equity share capital of its South African arm Cipla Medpro ...

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by ...

Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the ...